First new treatment for lupus in more than 52 years!

(Washington, DC, March 9, 2011) Today, the U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease.

Sandra C. Raymond, President and Chief Executive Officer of the Lupus Foundation of America (LFA), has issued the following statement regarding the FDA’s decision:

To read more, click here - http://www.lupus.org/newsite/pages/FDA-Approves-Benlysta.htm